ERIN SMITH/ SMITH CAPITOL STRATEGIES for TWIST BIOSCIENCE
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 15, 2020 | — | Replaced |
| 2nd Quarter - Termination (this page) | Jul 27, 2020 | — | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Science/Technology SCI
Supporting the bioeconomy COVID-19 synthetic biology policy H.R.4373 - Engineering Biology Research and Development Act of 2019 S. 3734 Bioeconomy Development Act of 2020 Biosecurity standards American competitiveness
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN F SMITH | — |
Budget/Appropriations BUD
H.R.2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020/ Senate: No bill number
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN F SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.